首页>投融资

Vico Therapeutics

B轮

Vico Therapeutics, established in 2019, is a biotech company focusing on the development of RNA modulating therapies for the treatment of rare severe neurological disorders.The company was founded by a former Prosensa's team, a company acquired by Biomarin in February 2015,.In July 2020, the company raised EUR 27 million (US $31 million) in a Series A financing round

https://vicotx.com/

470191

基本信息

公司全称

Vico Therapeutics BV
类型

RNA调节疗法开发商
产业领域

医药研发/制造、化学&生物药
公司人数

15~50人
地址

BioScience Park BioPartner Building 1 J.H. Oortweg 21 LEIDEN ZUID-HOLLAND 2333 CH; NL; Telephone: +31712036800;
联系电话

31 71 2036800
邮箱

info@vicotx.com
成立时间

2019-01-01

投融资

2024-06-24

B轮

1240万美元

Eurazeo

Seroba Life Sciences

DROIA

Ackermans & van Haaren

EQT Partners

Pureos Bioventures

Kurma Partners

Kurma Growth Opportunities Fund

Polaris Partners
2024-06-24

B轮

1240万美元

Seroba Life Sciences

Kurma Partners

Ackermans & van Haaren

DROIA

EQT Partners

Eurazeo

Polaris Partners

Kurma Growth Opportunities Fund

Pureos Bioventures
2024-01-05

B轮

6000万美元

Eurazeo

DROIA

Ackermans & van Haaren

EQT Partners

Pureos Bioventures

Kurma Partners

Polaris Partners
2024-01-05

B轮

6000万美元

Ackermans & van Haaren

Eurazeo

Pureos Bioventures

Polaris Partners

Kurma Partners

EQT Partners

DROIA
2020-07-29

A轮

3100万美元

Pontifax

Pureos Bioventures

Kurma Partners

Droia Genetic Disease

Life Science Partners

Idinvest Partners

Polaris Partners
2020-07-29

A轮

3100万美元

Kurma Partners

Life Science Partners

Idinvest Partners

Pureos Bioventures

Polaris Partners

Droia Genetic Disease

Pontifax
加载更多

Vico Therapeutics

基本信息

投融资

相关投融资企业